Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis.
about
Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis.Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.Drug development challenges and strategies to address emerging and resistant fungal pathogens.How disease advocacy organizations participate in clinical research: a survey of genetic organizations.Barriers to Cancer Clinical Trial Participation Among Saudi Nationals: A Cross-Sectional Study.Patient Empowerment and Involvement in Research.Factors affecting patient participation in clinical trials in Ireland: A narrative review.Recruitment procedures for descriptive socio-economic studies in rare diseases. The BURQOL-RD project
P2860
Q33905175-F8BC2D7A-E826-4F1A-A4ED-7AFCA12BE135Q38463698-CAAE1607-AD68-4440-AAC6-653F6EC89BB3Q38798805-A167A900-8337-4DF4-8680-02337D938A40Q45594506-794DD263-597F-4C87-A770-1CFAE7A7AEC8Q47686048-2759E1FD-76F4-4E98-A752-5071FC1CDE15Q50041279-77ADB450-2E09-4564-87FF-822E7DDA9487Q55342778-AF50CF43-AB9E-4CB0-BCF8-BD14623E9812Q57286748-EA02DFD0-3D7B-4617-B074-F9DFE8C79392
P2860
Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Predictors for clinical trial ...... ease lymphangioleiomyomatosis.
@ast
Predictors for clinical trial ...... ease lymphangioleiomyomatosis.
@en
type
label
Predictors for clinical trial ...... ease lymphangioleiomyomatosis.
@ast
Predictors for clinical trial ...... ease lymphangioleiomyomatosis.
@en
prefLabel
Predictors for clinical trial ...... ease lymphangioleiomyomatosis.
@ast
Predictors for clinical trial ...... ease lymphangioleiomyomatosis.
@en
P2093
P2860
P1433
P1476
Predictors for clinical trial ...... ease lymphangioleiomyomatosis.
@en
P2093
A C Sherman
Brent W Kinder
Francis X McCormack
J T Hagaman
P2860
P304
P356
10.1016/J.RMED.2009.09.023
P577
2009-12-04T00:00:00Z